Thiotepa Riemser Europeiska unionen - lettiska - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiski līdzekļi - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Lenalidomide Norameda 5 mg cietās kapsulas Lettland - lettiska - Zāļu valsts aģentūra

lenalidomide norameda 5 mg cietās kapsulas

norameda uab, lithuania - lenalidomīds - kapsula, cietā - 5 mg

Lenalidomide Norameda 10 mg cietās kapsulas Lettland - lettiska - Zāļu valsts aģentūra

lenalidomide norameda 10 mg cietās kapsulas

norameda uab, lithuania - lenalidomīds - kapsula, cietā - 10 mg